429 related articles for article (PubMed ID: 28964436)
1. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
Tina Shih YC; Dong W; Xu Y; Shen Y
Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
7. Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.
Phi XA; Greuter MJW; Obdeijn IM; Oosterwijk JC; Feenstra TL; Houssami N; de Bock GH
Breast; 2019 Jun; 45():82-88. PubMed ID: 30904701
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.
Sankatsing VDV; Juraniec K; Grimm SE; Joore MA; Pijnappel RM; de Koning HJ; van Ravesteyn NT
Radiology; 2020 Oct; 297(1):40-48. PubMed ID: 32749212
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
11. [Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China].
Mo M; Zheng Y; Liu G; Fang H; Zhang X; Zhai L; Chen Y; Lyu L; Zhu J; Luo J; Zhang L; Cao Z; Xu W; Shao Z
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):944-51. PubMed ID: 26887627
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Soto-Gordoa M; Sarriugarte G; Mar J
BMC Cancer; 2016 Jun; 16():344. PubMed ID: 27251556
[TBL] [Abstract][Full Text] [Related]
13. Total cost-effectiveness of mammography screening strategies.
Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
[TBL] [Abstract][Full Text] [Related]
14. Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.
Salikhanov I; Crape B; Howie P
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3153-3160. PubMed ID: 31653167
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.
Jahn B; Sroczynski G; Bundo M; Mühlberger N; Puntscher S; Todorovic J; Rochau U; Oberaigner W; Koffijberg H; Fischer T; Schiller-Fruehwirth I; Öfner D; Renner F; Jonas M; Hackl M; Ferlitsch M; Siebert U;
BMC Gastroenterol; 2019 Dec; 19(1):209. PubMed ID: 31805871
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Gray E; Donten A; Karssemeijer N; van Gils C; Evans DG; Astley S; Payne K
Value Health; 2017 Sep; 20(8):1100-1109. PubMed ID: 28964442
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
[No Abstract] [Full Text] [Related]
19. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis for breast cancer screening: double reading versus single + CAD reading.
Sato M; Kawai M; Nishino Y; Shibuya D; Ohuchi N; Ishibashi T
Breast Cancer; 2014 Sep; 21(5):532-41. PubMed ID: 23104393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
